Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Origin

Geographical scope

Document language

Publisher

Category

Organisation (author)

Search tool

Displaying 1 - 20 of 58

Document library

From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day

12.12.2022

This study provides an inventory of the SCs detected in the EU from 2008-2022, describing their structural evolution by analysing separately four structural features: their core, tail, linker, and linked groups.

Document library

EMCDDA framework and practical guidance for naming synthetic cannabinoids

08.11.2022

This work provides a theoretical framework and a practical hands-on guideline for consistent naming of synthetic cannabinoids, which is easy to understand and can be applied by the forensic community, researchers, clinical practitioners, and policy-makers.

Document library

Mortality involving New Psychoactive Substances across Europe, 2016- 2017

01.03.2022

This study aims to estimate the mortality related to NPS in Europe in 2016 and 2017.

Document library

Regulatory approaches to cannabidiol in the European Union

11.08.2021

The rapid growth in marketing cannabidiol poses a challenge to current European regulatory frameworks that can have important implications for consumer safety, public health, and established industries.

Document library

NEPTUNE New Psychoactive Substances Abbreviated Guidance (Georgian and Ukranian)

15.06.2021

This guidance is based on the NEPTUNE Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances made by the Novel Psychoactive Treatment: UK Network Project, hosted by the Central and Northwest London NHS Foundation Trust.

Document library

Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA

09.06.2021

This document links to the Commission Delegated Directive (EU) 2021/802 on MDMB-4en-PINACA and 4F-MDMB-BICA.

Document library

DARK classics in chemical neuroscience: etonitazene and related benzimidazoles

24.03.2021

Etonitazene and related 2-benzylbenzimidazoles are potent analgetics invented in the research laboratories of the Swiss pharmaceutical giant CIBA in the late 1950s.

Document library

Commission Delegated Directive on isotonitazene

13.11.2020

Isotonitazene is a synthetic opioid analgesic and is closely related to etonitazene and clonitazene, both of which are under international control under the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol.

Document library

Document library: COPOLAD early warning systems (EWS) on NPS and emerging drug phenomena

01.06.2020

This manual was developed with the goal of promoting and facilitating the establishment of Early Warning Systems (EWSs) and agreements for information exchange between National Drug Councils, National Drug Observatories and other key institutions in CELAC (Community of Latin American and Caribbea

Document library

New psychoactive substances: challenges for drug surveillance, control, and public health responses

21.10.2019

Document library

Council Decision on cyclopropylfentanyl and methoxyacetylfentanyl

28.09.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats (2)(3).

Document library

Inconsistencies in the assumptions linking punitive sanctions and use of cannabis and new psychoactive substances in Europe

28.06.2018

The level of drug use in the population is an ongoing topic of concern for policymakers, and regular adjustments to the penalty for this might reflect how much sanctions are viewed politically as appropriate to deter use.

Document library

World Drug Report 2018

26.06.2018

The UNODC World Drug Report is published annually and is considered a reference work on the global drug situation. It structured as a a series of five booklets, each focused on a different aspect of the drug problem.

Document library

Council Decision on ADB-CHMINACA

14.05.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Council Decision on CUMYL-4CN-BINACA

14.05.2018

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Regulation (EU) 2017/2101

15.11.2017

The legislation includes a stronger EU Early Warning System (EWS) and a faster risk-assessment process. The developments are in response to the recent growth in the market in NPS and follow a proposal from the European Commission (EC) comprising:

Document library

Council Decision on furanylfentanyl

15.11.2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Toxicovigilance of synthetic cannabinoids – Perspectives from the EU early warning system

20.10.2017

Document library

Council Decision on acryloylfentanyl

25.09.2017

This is the implementation decision of the Council of the EU, based on a proposal from the European Commission, was adopted in the final stage of the three-step legal procedure designed to respond to new psychoactive substances (NPS) that may pose public health and social threats.

Document library

Assessing the toxicological significance of new psychoactivesubstances in fatalities

01.06.2017
Loading